scholarly journals Are there autoantibodies reacting against citrullinated peptides derived from type I and type II collagens in patients with rheumatoid arthritis?

2005 ◽  
Vol 64 (10) ◽  
pp. 1443-1450 ◽  
Author(s):  
M-K Koivula
Keyword(s):  
Rheumatoid Arthritis ◽  
Type I ◽  
Type Ii

Sensitive immunoassays for the autoantibodies reacting against citrullinated carboxy-terminal telopeptides of type I and type II collagens in patients with rheumatoid arthritis

2005 ◽  
Vol 43 (12) ◽  
Author(s):  
Marja-Kaisa Koivula ◽  
Jarmo Ramberg ◽  
Sari Åman ◽  
Anna Karjalainen ◽  
Markku Hakala ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Synthetic Peptides ◽  
Type I ◽  
Type Ii ◽  
Sensitive Assay ◽  
Chemiluminescence Method ◽  
Assay Methods ◽  
Carboxy Terminal

AbstractWe developed sensitive assay methods for autoantibodies recognizing the citrullinated synthetic peptides derived from type I and type II collagens in patients with rheumatoid arthritis (RA). These peptides were tested with the chemiluminescence method (Nichols Advantage

Muscle morphology and enzymes in proximal and distal muscle groups of lower limb from patients with corticosteroid treated rheumatoid arthritis: the relationship to maximal isokinetic muscle strength

1986 ◽  
Vol 71 (6) ◽  
pp. 685-691 ◽  
Author(s):  
B. Danneskiold-Samsøe ◽  
G. Grimby
Keyword(s):  
Rheumatoid Arthritis ◽  
Muscle Strength ◽  
Gastrocnemius Muscle ◽  
Vastus Lateralis ◽  
Knee Extensors ◽  
Isokinetic Strength ◽  
Type I ◽  
Type Ii ◽  
Plantar Flexors ◽  
Isokinetic Muscle Strength

1. Abnormal morphological and enzymatic patterns in the lateral vastus muscle have been found in women with corticosteroid treated rheumatoid arthritis. By means of biopsies from the lateral heads of right gastrocnemius muscles, the histology and enzyme activities were compared with those found in right vastus lateralis biopsies. The findings were correlated with isometric and isokinetic strength of the plantar flexors. 2. The relative occurrence of type I fibres in the gastrocnemius muscle was 46.4 ± 18.7 (sd) %, which is significantly higher than found in the vastus lateralis [35.7 ± 13.3 (sd) %] (P < 0.03). 3. The relatively lower percentage of type II fibres in the gastrocnemius muscle was due to a relatively low percentage of type II A fibres [mean 27.9 ± 16.4 (sd) %] (P < 0.05). 4. The area of type I fibres in the gastrocnemius muscle was 26.1 × 102 ± 10.0 (sd) μm2, which is 74% of the mean area for type I fibres found in the vastus lateralis (P < 0.01). 5. The area of type II fibres in the gastrocnemius was 14.9 × 102 ± 7.1 (sd) μm2, which is 77% of the mean area for type II fibres found in the vastus lateralis. 6. The isokinetic muscle strength of the plantar flexors in corticosteroid treated patients with rheumatoid arthritis was reduced to less than 50% at all angular velocities when compared with healthy women. The same difference was found in the knee extensors. 7. Both type I and type II fibre areas correlated positively with the activity of β-hydroxyacyl-CoA dehydrogenase (r = 0.72, P < 0.02; r = 0.77, P < 0.01). The activity of the oxidative enzyme citric acid synthase (but not β-hydroxyacyl-CoA dehydrogenase) correlated positively with the isokinetic muscle strength of the plantar flexors at all the angular velocities (r = 0.75, P < 0.01; r = 0.57, P < 0.05). 8. The isokinetic strength as well as the type I and II fibre areas in the vastus lateralis biopsies correlated well with the same parameters in the gastrocnemius muscle (r approx. 0.70, P < 0.001). The vastus lateralis and the gastrocnemius muscles had similar morphology in the same subjects. In the control subjects and in the patients a close correlation was found between the isokinetic strength of the knee extensors and the plantar flexors. 9. It is concluded that the corticosteroid effect on muscles seems to occur in both the proximal and distal skeletal muscles.

The influence of prednisone on the muscle morphology and muscle enzymes in patients with rheumatoid arthritis

1986 ◽  
Vol 71 (6) ◽  
pp. 693-701 ◽  
Author(s):  
B. Danneskiold-Samsøe ◽  
G. Grimby
Keyword(s):  
Rheumatoid Arthritis ◽  
Muscle Strength ◽  
Vastus Lateralis ◽  
Knee Extension ◽  
Knee Extensors ◽  
Control Group ◽  
Type I ◽  
Type Ii ◽  
Muscle Enzymes ◽  
Muscle Morphology

1. Thirty-five female patients, mean age 63 years, suffering from rheumatoid arthritis participated the study. Twenty patients had been on long-term low-dose corticosteroid treatment. Fifteen patients had never received corticosteroids. A control group of 15 age- and sex-matched healthy subjects was also studied. 2. Examination of muscle biopsies from the (right) vastus lateralis and measurements of isokinetic and isometric knee-extension muscle strength were performed in all subjects. 3. Rheumatoid arthritis patients treated with corticosteroid showed a low percentage of type I fibres, mean 35.7 (range 17–66) % compared with patients who did not receive corticosteroid (P < 0.005). The latter group did not differ from the controls. 4. The muscle fibre areas also were affected in the corticosteroid treated rheumatoid patients. Type I and type II mean fibre areas were reduced by 32% and 50%, respectively, when compared with non-prednisone treated patients. The latter group did not differ from the controls in this respect. 5. A correlation was found between the isokinetic muscle strength of the knee extensors and the mean areas of type I and type II in patients treated with prednisone (r = 0.48, P < 0.05 and r = 0.58, P < 0.02 respectively). No such correlation was found when using isometric measurements of the knee extensors. A positive correlation was found in both groups of rheumatoid arthritis patients between the areas of the type I and type II fibres (r = 0.66–0.68, P < 0.05–0.02). 6. It is concluded that the observed abnormal muscle morphology and low knee-extension capacity found in the corticosteroid treated patients is due to the treatment rather than to other factors, as there were no other differences between the two groups of patients.

Heat-Etching with a Bullivant Type II Simple Freeze-Cleave Device

1970 ◽  
Vol 28 ◽  
pp. 106-107 ◽  
Author(s):  
Ronald S. Weinstein ◽  
N. Scott McNutt
Keyword(s):  
New Zealand ◽  
General Hospital ◽  
Massachusetts General Hospital ◽  
Type I ◽  
Type Ii ◽  
Collaborative Effort ◽  
Temperature And Pressure ◽  
The University

The Type I simple cold block device was described by Bullivant and Ames in 1966 and represented the product of the first successful effort to simplify the equipment required to do sophisticated freeze-cleave techniques. Bullivant, Weinstein and Someda described the Type II device which is a modification of the Type I device and was developed as a collaborative effort at the Massachusetts General Hospital and the University of Auckland, New Zealand. The modifications reduced specimen contamination and provided controlled specimen warming for heat-etching of fracture faces. We have now tested the Mass. General Hospital version of the Type II device (called the “Type II-MGH device”) on a wide variety of biological specimens and have established temperature and pressure curves for routine heat-etching with the device.

Labelling of non-A, non-B hepatitis infected chimpanzee hepatocytes with nuclease-gold conjugates

1984 ◽  
Vol 42 ◽  
pp. 250-251
Author(s):  
G. D. Gagne ◽  
M. F. Miller ◽  
D. A. Peterson
Keyword(s):  
Endoplasmic Reticulum ◽  
Experimental Infection ◽  
Uranyl Acetate ◽  
Type I ◽  
Cellular Injury ◽  
Type Ii ◽  
Tubular Structures ◽  
Type Iii ◽  
Type Iv ◽  
Infected Chimpanzee

Experimental infection of chimpanzees with non-A, non-B hepatitis (NANB) or with delta agent hepatitis results in the appearance of characteristic cytoplasmic alterations in the hepatocytes. These alterations include spongelike inclusions (Type I), attached convoluted membranes (Type II), tubular structures (Type III), and microtubular aggregates (Type IV) (Fig. 1). Type I, II and III structures are, by association, believed to be derived from endoplasmic reticulum and may be morphogenetically related. Type IV structures are generally observed free in the cytoplasm but sometimes in the vicinity of type III structures. It is not known whether these structures are somehow involved in the replication and/or assembly of the putative NANB virus or whether they are simply nonspecific responses to cellular injury. When treated with uranyl acetate, type I, II and III structures stain intensely as if they might contain nucleic acids. If these structures do correspond to intermediates in the replication of a virus, one might expect them to contain DNA or RNA and the present study was undertaken to explore this possibility.

Comparative surface and ultrastructural views of methylotrophic bacteria by TEM, STEM, SE, and freeze-etch electron microscopy.

1987 ◽  
Vol 45 ◽  
pp. 792-793
Author(s):  
T.A. Fassel ◽  
M.J. Schaller ◽  
M.E. Lidstrom ◽  
C.C. Remsen
Keyword(s):  
Cytoplasmic Membrane ◽  
Structural Features ◽  
Methylotrophic Bacteria ◽  
Type I ◽  
Type Ii ◽  
Membrane Complex ◽  
Oxidation Of Methane ◽  
Methane Oxidizing Bacteria ◽  
Wall Structures ◽  
Methylomonas Albus

Methylotrophic bacteria play an Important role in the environment in the oxidation of methane and methanol. Extensive intracytoplasmic membranes (ICM) have been associated with the oxidation processes in methylotrophs and chemolithotrophic bacteria. Classification on the basis of ICM arrangement distinguishes 2 types of methylotrophs. Bundles or vesicular stacks of ICM located away from the cytoplasmic membrane and extending into the cytoplasm are present in Type I methylotrophs. In Type II methylotrophs, the ICM form pairs of peripheral membranes located parallel to the cytoplasmic membrane. Complex cell wall structures of tightly packed cup-shaped subunits have been described in strains of marine and freshwater phototrophic sulfur bacteria and several strains of methane oxidizing bacteria. We examined the ultrastructure of the methylotrophs with particular view of the ICM and surface structural features, between representatives of the Type I Methylomonas albus (BG8), and Type II Methylosinus trichosporium (OB-36).

Sign in / Sign up

Export Citation Format

Share Document